Behe; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Behe; Martin.The latest application filed is for "transglutaminase conjugation method with a glycine based linker".

Company Profile

5.4.12

Behe; Martin - Gelterkinden CH
Behe; Martin - Gelterkinde CH
Behe; Martin - Marburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase MTG and MTG in solution Grant 11,396,649 - Spycher , et al. July 26, 2	2022-07-26
Transglutaminase Conjugation Method With A Glycine Based Linker App 20220133904 - SCHIBLI; Roger ; et al.	2022-05-05
Minigastrin Derivates, In Particular For Use In Cck2 Receptor Positive Tumour Diagnosis And/or Treatment App 20210361735 - BEHE; MARTIN ; et al.	2021-11-25
Mini-gastrin Analogue, In Particular For Use In Cck2 Receptor Positive Tumour Diagnosis And/or Treatment App 20210145990 - BEHE; Martin ; et al.	2021-05-20
Transglutaminase Conjugation Method And Linker App 20210128743 - Spycher; Philipp ; et al.	2021-05-06
Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment Grant 10,953,114 - Behe , et al. March 23, 2	2021-03-23
Fibronectin-binding Peptides For Use In Tumor Or Fibrosis Diagnosis And Therapy App 20200181211 - CHABRIA; Mamta ; et al.	2020-06-11
Mini-gastrin Analogue, In Particular For Use In Cck2 Receptor Positive Tumour Diagnosis And/or Treatment App 20190240360 - Behe; Martin ; et al.	2019-08-08
Site-specific Conjugation To Antibody Lysine Residues With Solid-phase Immobilized Microbial Transglutaminase Mtg And Mtg In Sol App 20190194641 - SPYCHER; PHILIPP RENE ; et al.	2019-06-27
Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment Grant 10,130,724 - Behe , et al. November 20, 2	2018-11-20
Mini-gastrin Analogue, In Particular For Use In Cck2 Receptor Positive Tumour Diagnosis And/or Treatment App 20160256580 - BEHE; MARTIN ; et al.	2016-09-08
Peptide Derivatives Of Exendin-4 App 20130095037 - GOTTHARDT; Martin ; et al.	2013-04-18
Peptide derivatives of exendin-4 Grant 8,268,781 - Gotthardt , et al. September 18, 2	2012-09-18
Invention concerning GLP-1 and exendin App 20090180953 - Gotthardt; Martin ; et al.	2009-07-16
Modified minigastrin analogs for oncology applications App 20070041903 - Maina; Theodosia ; et al.	2007-02-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.